Spectral Medical Provides Tigris Trial Update
10 avr. 2024 07h00 HE
|
Spectral Medical Inc.
101 patients enrolled TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
Spectral Medical Chair to Retire From the Board of Directors
02 avr. 2024 08h00 HE
|
Spectral Medical Inc.
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
28 mars 2024 16h00 HE
|
Spectral Medical Inc.
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Provides February Tigris Trial Update
28 févr. 2024 07h30 HE
|
Spectral Medical Inc.
93 patients enrolledFebruary represents a second record breaking consecutive month for patient enrollment TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
21 févr. 2024 16h00 HE
|
Spectral Medical Inc.
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients
15 févr. 2024 07h41 HE
|
Spectral Medical Inc.
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Provides Early February Tigris Trial Update
05 févr. 2024 07h30 HE
|
Spectral Medical Inc.
88 patients enrolled January being the highest enrollment month since the launch of Tigris TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Provides January Tigris Trial Update
30 janv. 2024 07h30 HE
|
Spectral Medical Inc.
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial
10 janv. 2024 07h00 HE
|
Spectral Medical Inc.
New patient enrollment sites accelerating screening activityScreening activity exceeding 100 patients per weekApproaching interim enrollment target of 90 patients TORONTO, Jan. 10, 2024 (GLOBE...
Spectral Medical Provides Tigris Trial Update
14 déc. 2023 08h00 HE
|
Spectral Medical Inc.
81 patients enrolled TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...